← Leaderboards
Marat Khodoun
University Of Cincinnati
$1,321,587
Attributed
$2,643,173
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $585.7K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,643,173 · 1
By mechanism
R01$2,643,173 · 1
Top collaborators
- Fred Douglass Finkelman5 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- Fred Douglass Finkelman$18,476,629
- Andrew B Norman$25,974,738
- Khawaja H Haider$4,240,527
- Meifeng Xu$4,938,461
- Yigang Wang$11,973,905
Others in their field
Other Emerging Leaders on “Dose”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
Research focus
DoseAdverse EffectsAllergensAffectAffinityAnaphylaxisAnergyAnimal ModelAnimalsAllergicAllergic DiseaseAntigensBasophilsBindingBlood CellsCellsClinical TrialsComplementComplement ReceptorCrosslinkAntibodiesCytokineDesensitizationEndocytosis
Grant awards (5)
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$541,238
R01 · FY2023 · AI
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$566,118
R01 · FY2022 · AI
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$566,118
R01 · FY2021 · AI
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$585,704
R01 · FY2020 · AI
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$383,995
R01 · FY2019 · AI